FDA Inspection 1047506 — Stephen Falkowski D.O.
The FDA completed an inspection of Stephen Falkowski D.O. on Mar 28, 2018 in Chiefland, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 28, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chiefland, FL (United States)
Additional Details
Clinical Investigator (CI)